Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with <i>MEF2D</i> fusions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcome and molecular measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia patients with MEF2D fusions

Published:2022-12-19 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Sun Kai¹,Chen Wen‐Min¹,Wang Xu¹,Zhao Xiao‐Su¹,Li Ling‐Di¹,Hao Yue¹,Wang Jun¹,Xu Nan¹,Jiang Qian¹,Jiang Hao¹,Xu Lan‐Ping¹,Wang Yu¹^ORCID,Zhang Xiao‐Hui¹,Huang Xiao‐Jun¹,Qin Ya‐Zhen¹^ORCID

Affiliation:

1. Peking University People's Hospital Peking University Institute of Hematology National Clinical Research Center for Hematologic Disease Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation Beijing China

Funder

Capital Health Research and Development of Special Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3114

Reference14 articles.

1. Genetic Basis of Acute Lymphoblastic Leukemia

2. Acute lymphoblastic leukemia: a comprehensive review and 2017 update

3. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

4. MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP